Algorae Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Jun 23 | BuyAU$898,904 | Chunyan Niu | Individual | 78,430,790 | AU$0.011 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 25,000,000 | 1.48% |
Institutions | 50,000,000 | 2.96% |
Individual Insiders | 281,008,442 | 16.7% |
Private Companies | 330,261,205 | 19.6% |
General Public | 1,001,125,084 | 59.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
86,304,090 | AU$949.3k | 0% | no data | |||
50,000,000 | AU$550.0k | 0% | 64.05% | |||
50,000,000 | AU$550.0k | 0% | no data | |||
48,366,666 | AU$532.0k | 0% | no data | |||
47,930,832 | AU$527.2k | 0% | no data | |||
42,000,000 | AU$462.0k | 0% | no data | |||
41,141,666 | AU$452.6k | 0% | no data | |||
37,666,667 | AU$414.3k | 0% | no data | |||
30,375,420 | AU$334.1k | 0% | no data | |||
28,482,728 | AU$313.3k | 0% | no data | |||
27,150,000 | AU$298.7k | 0% | no data | |||
25,000,000 | AU$275.0k | 0% | no data | |||
24,000,000 | AU$264.0k | 0% | no data | |||
20,079,728 | AU$220.9k | 0% | no data | |||
20,000,000 | AU$220.0k | 0% | no data | |||
20,000,000 | AU$220.0k | 0% | no data | |||
20,000,000 | AU$220.0k | 0% | no data | |||
19,528,291 | AU$214.8k | 0% | no data | |||
19,518,750 | AU$214.7k | 0% | no data | |||
16,850,000 | AU$185.3k | 0% | no data | |||
5,625,000 | AU$61.9k | 0% | no data | |||
5,000,000 | AU$55.0k | 0% | no data | |||
1,125,000 | AU$12.4k | 0% | no data | |||
63,474 | AU$697.9 | 0% | no data | |||
61,335 | AU$673.8 | 0% | no data |